MESO FY 2019 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M-3.6% YoY

Gross Profit

-$58M-349.5% margin

Operating Income

-$80M-479.6% margin

Net Income

-$90M-537.0% margin

EPS (Diluted)

$-1.80

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$58M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$652M

Total Liabilities

$171M

Stockholders' Equity

$481M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$17M	-3.6%
Gross Profit	-$58M	$12M	-594.0%
Operating Income	-$80M	-$77M	-3.7%
Net Income	-$90M	-$35M	-154.5%